Status:

WITHDRAWN

Theophylline for Depression Study

Lead Sponsor:

University of California, Los Angeles

Conditions:

Depression

Eligibility:

All Genders

18-65 years

Phase:

EARLY_PHASE1

Brief Summary

Depression is very common and poses a huge disease burden. About 20% of the US population suffers from depression at least once in their lifetime. Inflammations that are hidden inside our body as a re...

Eligibility Criteria

Inclusion

  • in good general health (as evaluated during the phone and in-person screening sessions)
  • aged 18-65 years
  • if female, using adequate birth control

Exclusion

  • history of hypersensitivity to xanthine derivatives (a contraindication to theophylline treatment)
  • pregnant or planning to become pregnant in the next 6 months
  • current breastfeeding
  • chronic diseases such as cardiovascular disease, hepatic impairment, peptic ulcer disease, and seizure disorders
  • current use of prescription medications such as steroids, non-steroid anti-inflammatory drugs, immune modifying drugs, opioid analgesics, and psychotropics
  • Axis I psychiatric disorders including current major depressive disorder
  • current depressive symptoms assessed by the Patient Health Questionnaire (PHQ-9 ≥ 5)
  • heavy smoking (1 pack or more per day)
  • excessive caffeine use (\>600 mg/day)
  • Body-mass index \> 35 due to the effects of obesity on cytokine activity
  • evidence of recreational drug use from urine test
  • evidence of pregnancy from urine test
  • evidence of clinically significant rhythm abnormality on a resting electrocardiogram (ECG)
  • clinically significant abnormalities on screening laboratory tests

Key Trial Info

Start Date :

March 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2025

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04309877

Start Date

March 1 2023

End Date

June 1 2025

Last Update

November 5 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UCLA Cousins Center for Psychoneuroimmunology

Los Angeles, California, United States, 90095